Viral lower respiratory tract infections (LRTIs) can present with a variety of computed tomography (CT) findings. However, identifying the contribution of a particular virus to CT findings is challenging due to concomitant infections and the limited data on the CT findings in viral LRTIs. We therefore investigate the CT findings in different pure viral LRTIs.
Introduction
Lower respiratory tract infection (LRTI) refers to a broad clinical entity of acute respiratory infections resulting in lower respiratory signs or symptoms such as sputum, dyspnea, wheezing, or crackles, wherein tracheobronchitis, bronchiolitis, and pneumonia are included. [1] [2] [3] Respiratory viruses are increasingly recognized as important pathogens causing LRTI. [4] [5] [6] [7] [8] [9] [10] [11] [12] Parainfluenza virus (PIV), influenza virus, and respiratory syncytial virus (RSV) are the 3 most common respiratory viruses documented in LRTI and are the important pathogens which can potentially lead to fatal outcomes particularly in immunocompromised patients. [13] [14] [15] [16] [17] [18] Discriminating the viral LRTIs caused by PIV, influenza virus, and RSV, however, remains problematic due to nonspecific clinical presentations which have considerable overlaps among them. [6, 7, 14] The radiologic appearances of these viral LRTIs are also unclear, because they are frequently accompanied by infections by bacteria, fungi, mycobacteria, or other viruses, and data on the radiologic findings of the individual viruses are very limited. Examination of bronchoalveolar lavage (BAL) often permits a definitive diagnosis, but is not always feasible due to the unstable clinical conditions especially in critically ill patients. Hence, better understanding of the radiologic findings in viral LRTIs could assist physicians in establishing their viral etiology, employing empirical antiviral agents, and obviating unnecessary antibacterial treatments.
A few studies have evaluated computed tomography (CT) findings in LRTIs caused by PIV, influenza virus, and RSV. Nevertheless, they were flawed by important limitations. Since they predominantly relied for virus identification on upper respiratory specimens such as nasopharyngeal aspirates or swabs, the viruses detected could indicate coincidental upper respiratory tract infections. Furthermore, only a limited number of patients with severe viral LRTIs were included. We therefore analyzed the CT findings in LRTIs in which BAL was performed because of their severity and in which PIV, influenza virus, or RSV were proven from the BAL samples to be the culprits.
Methods

Study population
This study was performed at the Asan Medical Center, a 2700-bed tertiary hospital in Seoul, South Korea, from January 1998 to December 2014. All adult patients aged ≥16 years, who underwent BAL and were diagnosed with LRTIs caused by PIV, influenza virus, or RSV, were enrolled. Chest CTs obtained from these patients were identified and reviewed. The need for informed consent was waived in view of the observational nature of the study.
Virus identification
In all cases, a diagnosis of LRTI caused by PIV, influenza virus, or RSV was established when the patient developed new-onset lower respiratory tract signs or symptoms such as sputum, dyspnea, wheezing, or crackles, and each virus was confirmed by viral culture of BAL samples only. We employed a shell vial culture (Diagnostic Hybrids, Inc., Athens, USA) that can detect PIV, influenza virus, RSV, cytomegalovirus, and adenovirus. The medical records of the patients with confirmed viral LRTIs were reviewed, and the patients with "pure" viral LRTI were finally analyzed. Pure viral LRTI was defined as a positive viral culture from BAL samples without any evidence of concomitant infection with other pathogens; patients giving positive respiratory or blood cultures, polymerase chain reaction (PCR), or serologic tests for bacteria, fungi, or mycobacteria were excluded. Patients infected with 2 or more respiratory viruses were also excluded.
CT analysis
Chest CT scans with or without contrast enhancement of the patients with pure viral LRTIs, obtained within 2 weeks of the date of viral culture, were retrospectively analyzed. Two radiologists with 19 (MYK) and 6 (HJL) years of experience, respectively, who were blind to the patients' characteristics and clinical outcomes, independently reviewed the CT images and reached final decisions by consensus. In addition, the CT findings were compared to see whether there were any radiologic differences between infections with PIV, influenza virus, and RSV.
Various generations of CT scanners were used for this study. Most of the chest CT examinations were performed with a SOMATOM (Siemens Medical Solutions, Forchheim, Germany) or a Lightspeed Volume CT (VCT) (General Electric Medical Systems, Milwaukee, WI). The reconstruction intervals were 5 mm, with a 5 mm interval without a gap for the B50 algorithm and a 1 mm reconstruction with a 5 mm gap for the B60 algorithm. Imaging was obtained at sustained full inspiration, and the scan range was from the supraclavicular area to the level of the adrenal glands. All the images were viewed on the mediastinal (width: 450 HU; level: 50 HU) and lung window (width: 1500 HU; level: À700 HU) axial image settings on the picture archiving and communication system (PACS).
Radiologic findings and definitions
The CT morphologies of pure viral LRTIs were examined for the presence or absence of the following findings: patch consolidation (≥1 cm or more than 1 segmental level), multifocal consolidations (<1 cm and more than 3 in number), groundglass opacities, centrilobular nodules, bronchial wall thickening, interlobular septal thickening, pleural effusion, and normal appearance. Each finding was preferentially defined according to the criteria of the Fleischner Society glossary of terms. [41] Distinction between patch consolidation and multifocal consolidations was made by extent and number of the lesions: patch consolidation referred to relatively large (≥1 cm) or extensive (more than 1 segmental level) lesion, however, multifocal consolidations indicated relatively small (<1 cm) and multiple (more than 3) ones. Bronchial wall thickening was determined to be present, in accordance with the previous studies, if the bronchus seemed more prominent than the adjacent artery in the absence of bronchiectasis. [24, [32] [33] [34] Normal appearance was defined as the absence of pathologic findings except for preexisting lung parenchymal conditions such as emphysema, bronchiectasis, or interstitial lung disease (ILD). Furthermore, the anatomical distribution of changes was analyzed according to their zonal predominance (upper and mid, lower, and whole lung), localization (segmental and lobar, diffuse and random, and other), and symmetry (bilateral, unilateral).
Unlike previous studies, we did not exclude patients with preexisting lung parenchymal diseases such as ILD, chronic obstructive lung disease (COPD), and solid tumors involving the lungs. Previous studies excluded these patients because preexisting lung lesions can make it difficult to identify those changes developed by the viral LRTIs. However, these patients are of particular concern for viral LRTIs, and they might be helped if the CT findings permitted early diagnosis of the virus involved. Therefore, we decided to include them in our analysis. The newly appeared CT findings were identified by comparing the images with the underlying lesions seen in the previous or following CT images.
Statistical analysis
Statistical analyses were performed to compare the CT findings in infections by the 3 different viruses. The SPSS for Windows software package, version 20.0 (SPSS Inc, Chicago, IL) was used. Categorical variables were compared using the x 2 or Fisher exact test, and continuous variables were compared using the Mann-Whitney U test. A P-value < 0.05 were considered statistically significant.
Results
Clinical characteristics of patients
A total of 139 patients were diagnosed with LRTIs with PIV, influenza virus, and RSV using viral culture of BAL samples. Of these patients, 37 did not undergo CT scans, and 6 were excluded because the interval between CT scan and viral culture was more 95: 26 Medicine than 2 weeks. Fifty-six patients who had concurrent infection with other pathogens were also excluded (see Fig. 1 ). Finally, the CT findings for 40 patients having pure viral LRTI were analyzed: 14 with PIV, 14 with influenza virus, and 12 with RSV. The baseline clinical characteristics and outcomes of these 40 patients are shown in Table 1 . There was a significant seasonal variation in occurrence: PIV infections happened predominantly in summer, whereas influenza virus and RSV infections occurred mostly in winter (P < 0.001). The patients with influenza virus (79%) LRTIs received antiviral treatment, consisting of oseltamivir or peramivir, more frequently than those with PIV (36%) or RSV (33%) LRTIs (P = 0.03). Other baseline clinical characteristics and outcomes were not significantly different between the 3 groups.
CT findings in viral LRTIs
The individual respiratory viruses tended to generate several characteristic CT findings despite considerable overlap between them. The image findings are summarized in Table 2 . Patch consolidation (≥1 cm or more than 1 segmental level) was found only in PIV LTRIs (29%) (P = 0.03) and made these LTRIs look like bacterial infections. The representative images of PIV LRTI are shown in Fig. 2 . All cases of influenza virus had ground-glass opacities, which were more frequent than in PIV (71%) and RSV (67%) LTRIs (P = 0.05) (Fig. 3) . Bronchial wall thickening was more common in influenza virus (71%) and RSV (67%) infections than in PIV infections (21%) (P = 0.02) (Fig. 4) . Therefore, the CT images of influenza virus and RSV LTRIs could seem to be more compatible with viral infections than those of PIV LTRIs. We did not detect any significant differences between the 3 viruses in terms of multifocal consolidations (<1 cm and more than 3 in number), centrilobular nodules, interlobular septal thickening, pleural effusion, and normal appearance. Data are no. (%) of patients unless indicated otherwise. ALC = absolute lymphocyte count, ANC = absolute neutrophil count, COPD = chronic obstructive pulmonary disease, HCT = hematopoietic stem cell transplantation, ICU = intensive care unit, PIV = parainfluenza virus, RSV = respiratory syncytial virus, SD = standard deviation. * This patients had a myasthenia gravis. † Immunosuppressive condition is defined as presence of underlying diseases, such as HIV infection, malignancy, liver cirrhosis, and chronic renal failure, and/or receipt of immunosuppressive treatment.
‡ Oral ribavirin and intravenous immunoglobulin (IVIg) were used.
x Oral oseltamivir and intravenous peramivir were used. Differences of anatomical distribution were also noted for the individual respiratory virus LTRIs (Table 2) . Each virus had a tendency to prefer a certain area of the lungs (P = 0.06): CT findings of PIV LTRIs were predominantly found in the lower lungs (69%), those of influenza virus in the whole lungs (57%), and those of RSV in the upper and mid lungs (44%). PIV (62%) and influenza virus (79%) LTRIs frequently showed a diffuse distribution, whereas RSV predominantly revealed a segmental and lobar distribution (67%); however, the difference was not statistically significant (P = 0.09). All cases of RSV demonstrated a bilateral distribution, unlike PIV LTRIs (54%) and influenza virus LTRIs (43%) (P = 0.02).
In short, PIV LTRIs occasionally presented with patch consolidation (≥1 cm or more than one segmental level) located in the lower lobes (Fig. 2) . Influenza virus LTRIs mostly exhibited diffuse ground-glass opacities over the whole lung (Fig. 3) , and RSV LTRIs often formed localized and bilateral patterns, which were more often in the upper and mid lobes (Fig. 4) . It was notable that CT images of all 3 types of LTRI often contained multifocal consolidations (<1 cm and more than three in number) were obtained at the levels of the main stem bronchi and segmental bronchi of both lower lobes. Note the ill-defined centrilobular nodules (arrows) in both lungs, predominantly in the right middle lobe and both lower lobes. Note also the diffuse bronchial wall thickening (arrow heads) in the right lower lobe. Table 3 Previous studies upon the CT finding in LRTIs caused by PIV, influenza virus, and RSV.
CT findings
First author [ref.] Year Number of patients Specimen Assay PIV
Influenza virus RSV
Mayer [27] 2014 RSV 51 Throat swab, BAL, etc.
PCR Ground-glass opacities, consolidations * Herbst [24] 2013 PIV 24 Nasopharyngeal swab, BAL PCR Bronchial wall thickening, tree-in-bud opacities, consolidation Lee [20] 2013 Influenza virus 98 Nasopharyngeal swab, PCR Ground-glass opacities, consolidations Wang [19] 2013 Influenza virus 12 Nasopharyngeal swab, PCR Ground-glass opacities, consolidations Syha [28] 2012 RSV 13 NA Culture Ground-glass opacities, consolidations, centrilobular opacities Li [21] 2012 Influenza virus 70 NA PCR Ground-glass opacities, consolidations El-Badrawy [22] 2012 Influenza virus 12 BAL PCR, IF Bronchial wall thickening, ground-glass opacities, consolidations Miller [32] 2011 Influenza virus 60, RSV 19 Nasopharyngeal swab, BAL PCR Various findings, normal Bronchial wall thickening, tree-in-bud opacities Marchiori [23] 2011 NA NA NA Consolidations, groundglass opacities Shiley [34] 2010 PIV 4, Influenza virus 21, RSV 8 Nasopharyngeal swab, BAL PCR Tree-in-bud opacities, consolidations
Normal, ground-glass opacities
Tree-in-bud opacities Ferguson [25] 2009 PIV 6 Nasopharyngeal aspirate, BAL
Culture, PCR, IF
Multiple small nodules Kanne [35] 2007 NA NA NA Consolidations, centrilobular nodules, ground-glass opacities,
Ground-glass opacities, consolidations, centrilobular nodules Centrilobular nodules, ground-glass opacities, consolidation Kim [40] 2002 NA NA NA Consolidations, groundglass opacities, Ko [29] 2000 RSV 10 Nasopharyngeal swab, BAL In the study, the most characteristic CT findings at the beginning of RSV pneumonia were nodules, tree-in-bud opacities, and bronchial wall thickening. 
Discussion
We have identified certain specific characteristics of the CT findings in patients with LRTIs due to PIV, influenza virus, and RSV. The PIV LRTIs were distinctive in leading to patchy consolidation (≥1 cm or more than 1 segmental level) and were preferentially located in the lower lobes of the lung with a diffuse distribution. Patients with influenza virus LRTIs had groundglass opacities frequently diffused over the whole lungs. Influenza virus and RSV LRTIs often had bronchial wall thickenings, and RSV LRTIs were predominantly localized in the upper and mid lobes. Several studies have previously evaluated the CT findings in LRTIs caused by PIV, influenza virus, and RSV (Table 3) . In PIV LRTIs, Herbst et al [24] mainly observed bronchial wall thickenings and tree-in-bud opacities. Ferguson et al [25] reported multiple small nodules (<5 mm) in 6 patients with PIV LRTIs. However, the previous findings are not consistent with our data for PIV LRTIs, which were characterized by patch consolidation, ground-glass opacities, and multifocal consolidations. This discrepancy could be due to the fact that the earlier studies included only a limited number of severe cases, so that the potential CT findings of severe PIV infections were not fully evaluated. For influenza virus, several studies consistently found ground-glass opacities and consolidations, [19] [20] [21] [22] [23] 32, 34, 35] which is in line with our findings. For RSV, bronchial wall thickening and centrilobular opacities were considered to predominate in view of the frequent presentation of bronchiolitis. [27] [28] [29] 32, 34, 35] The present study confirmed that bronchial wall thickening was frequently seen in RSV infections, although RSV could manifest as ground-glass opacities or consolidations in severe cases.
The availability of the PCR has greatly improved the identification of viral pathogens in respiratory tract infections, compared with conventional virological diagnostic methods such as serologic tests and viral culture. [6, 7, [9] [10] [11] [12] However, positivity in virus PCR, which indicates the presence of viral genomes, may not always imply an active infection, because false positivity is possible in the cases of past infection or colonization by the virus. [13] However, positive culture of virus, which demonstrates the presence of viable virus, strongly suggests active infection. We believe that identification of living virus by culture from BAL is the most reliable method of proving a virus to be the pathogen. We therefore employed viral culture rather than virus PCR to detect pure viral LRTIs.
Our study has a few limitations. First, we only included the patients who underwent BAL and CT. Thus, there could have been a selection bias toward more severe LRTIs, and CT findings of relatively mild cases might be underestimated. Second, some may argue that concomitant bacterial LRTI could not be definitely ruled out due to the relative insensitivity of conventional culture for bacterial respiratory pathogens resulting LRTIs. However, most studies in this area have used similar practical criteria for viral LRTIs in the real world. [24, 25, 32, 36] In addition, if such confounding by concomitant bacterial infection did occur, it would be more likely to lead to a bias toward the null hypothesis. Third, CT findings in early stage of viral LRTI may be distinct from those in late stage. However, we could not compare the CT findings according to different stages of disease due to the relatively small number of our patients. Last, the imaging techniques used for CT examinations were heterogeneous because of the observations made extended over a long time.
In conclusion, LRTIs due to PIV, influenza virus, and RSV each have characteristic features in CT images despite considerable overlap between them. Our findings could help in the early differentiation of these viruses and the empirical use of appropriate antiviral agents.
